Cathay Biotech Inc. (SHA:688065)
China · Delayed Price · Currency is CNY 39.03
-0.18 (-0.46%)
Nov 6, 2026, 3:00 PM CST
Cathay Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,413 | 3,120 | 2,819 | 2,067 | 2,332 | 2,296 |
Other Revenue | 174.63 | 174.63 | 138.84 | 47.17 | 108.67 | 67.67 |
| 3,588 | 3,295 | 2,958 | 2,114 | 2,441 | 2,363 | |
Revenue Growth | 9.13% | 11.40% | 39.91% | -13.39% | 3.28% | 57.86% |
Cost of Revenue | 2,497 | 2,304 | 2,121 | 1,535 | 1,612 | 1,526 |
Gross Profit | 1,091 | 991.2 | 836.44 | 579.23 | 829.2 | 837.21 |
Selling, General & Admin | 251.02 | 234.5 | 222 | 221.61 | 232.28 | 175.11 |
Research & Development | 264.98 | 237.89 | 233.34 | 189.13 | 187.71 | 133.53 |
Other Operating Expenses | -37.79 | -19.69 | -18.34 | 9.21 | -4.09 | 22.94 |
Operating Expenses | 474.28 | 464.43 | 440.34 | 413.68 | 422.59 | 337.95 |
Operating Income | 616.84 | 526.78 | 396.1 | 165.55 | 406.61 | 499.25 |
Interest Expense | -0.1 | -8.79 | -27.43 | -32.17 | -20.01 | -16.29 |
Interest & Investment Income | 43.23 | 185.6 | 160.75 | 219.77 | 236.78 | 229.61 |
Earnings From Equity Investments | - | - | - | -7.82 | -3.71 | - |
Currency Exchange Gain (Loss) | -72.91 | -72.91 | 36.73 | 29.59 | 82.97 | -14.14 |
Other Non Operating Income (Expenses) | 55.39 | -3.63 | -6.04 | -5.7 | -4.61 | -0.59 |
EBT Excluding Unusual Items | 642.45 | 627.04 | 560.11 | 369.22 | 698.03 | 697.84 |
Gain (Loss) on Sale of Investments | -14.07 | - | -8.95 | - | - | - |
Gain (Loss) on Sale of Assets | -0.05 | 6.71 | 0.42 | -0.01 | 0.07 | - |
Asset Writedown | 98.32 | -0.03 | -0.05 | -0.26 | -0.02 | -0.06 |
Other Unusual Items | 4.84 | -3.56 | -3.51 | 79.97 | -2.09 | 26.66 |
Pretax Income | 731.49 | 630.16 | 548.02 | 448.92 | 695.99 | 724.45 |
Income Tax Expense | 101.21 | 100.66 | 73.43 | 40.39 | 83.34 | 90.94 |
Earnings From Continuing Operations | 630.29 | 529.5 | 474.59 | 408.54 | 612.65 | 633.51 |
Minority Interest in Earnings | 6.72 | 31.22 | 14.37 | -42.01 | -59.39 | -38.79 |
Net Income | 637 | 560.72 | 488.96 | 366.52 | 553.27 | 594.72 |
Net Income to Common | 637 | 560.72 | 488.96 | 366.52 | 553.27 | 594.72 |
Net Income Growth | 7.16% | 14.68% | 33.41% | -33.75% | -6.97% | 29.94% |
Shares Outstanding (Basic) | 721 | 684 | 582 | 582 | 582 | 583 |
Shares Outstanding (Diluted) | 721 | 684 | 582 | 582 | 582 | 583 |
Shares Change | 11.26% | 17.47% | 0.05% | -0.10% | -0.11% | 7.38% |
EPS (Basic) | 0.88 | 0.82 | 0.84 | 0.63 | 0.95 | 1.02 |
EPS (Diluted) | 0.88 | 0.82 | 0.84 | 0.63 | 0.95 | 1.02 |
EPS Growth | -3.68% | -2.38% | 33.33% | -33.68% | -6.86% | 21.01% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -285.43 | -339.34 | -22.38 | -1,000 | -3,395 | -880.49 |
Free Cash Flow Per Share | -0.40 | -0.50 | -0.04 | -1.72 | -5.83 | -1.51 |
Dividend Per Share | 0.450 | 0.450 | 0.400 | 0.190 | 0.180 | 0.321 |
Dividend Growth | 12.50% | 12.50% | 110.53% | 5.56% | -43.99% | -43.75% |
Gross Margin | 30.41% | 30.08% | 28.28% | 27.40% | 33.97% | 35.42% |
Operating Margin | 17.19% | 15.99% | 13.39% | 7.83% | 16.66% | 21.12% |
Profit Margin | 17.75% | 17.02% | 16.53% | 17.34% | 22.66% | 25.16% |
Free Cash Flow Margin | -7.95% | -10.30% | -0.76% | -47.32% | -139.06% | -37.25% |
EBITDA | 919.33 | 837.27 | 717.26 | 451.26 | 671.73 | 667.79 |
EBITDA Margin | 25.62% | 25.41% | 24.25% | 21.34% | 27.52% | 28.25% |
D&A For EBITDA | 302.49 | 310.49 | 321.16 | 285.72 | 265.12 | 168.54 |
EBIT | 616.84 | 526.78 | 396.1 | 165.55 | 406.61 | 499.25 |
EBIT Margin | 17.19% | 15.99% | 13.39% | 7.83% | 16.66% | 21.12% |
Effective Tax Rate | 13.84% | 15.97% | 13.40% | 9.00% | 11.97% | 12.55% |
Revenue as Reported | 750.01 | 3,295 | 2,958 | 2,114 | 2,441 | 2,363 |